Home > Our Work > Biomedical Initiatives

Biomedical Initiatives

We invest in individuals and organizations in diverse life sciences fields whose work breaks traditional paradigms to advance understanding, research and treatment in their respective fields.

Our Work

We recognize that many innovators are ahead of their time and may face difficulties securing funding from traditional sources.

Dr. Charalambos (Babbis) Andreadis University of California, San Francisco Baszucki Lymphoma Therapeutics Initiative: Chimeric Antigen Receptor T-Cell (CAR-T Therapy) Read more
Dr. Rhiju Das Stanford University mRNA COVID-19 Vaccine Research: Improving transport of mRNA vaccines Read more
Dr. Robin Franklin, Dr. Yorgo Modis and Dr. Adam Young University of Cambridge Conserved structures in the viral macrodomain of rubella virus confers protection against SARS-CoV-2-induced pulmonary pathology Read more
Dr. Mark Hellerstein University of California, Berkeley Durability and quality of virus-specific T-cells after COVID-19 RNA vaccination Read more
Dr. John Winkelman Massachusetts General Hospital Improving Treatments for Restless Legs Syndrome (RLS) including the National RLS Opioid Registry, RLS Curbside Initiative, and the Mass General RLS Quality Care Center Read more